These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19284061)

  • 1. The gender paradox.
    Presbitero P
    EuroIntervention; 2009 Jan; 4(4):415, 417. PubMed ID: 19284061
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II.
    Vaina S; Voudris V; Morice MC; De Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Schuijer M; Macours N; Stoll HP; Cokkinos DV; Stefanadis C; Serruys PW;
    EuroIntervention; 2009 Jan; 4(4):492-501. PubMed ID: 19284072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of drug-eluting stents in women: a window of opportunity.
    Jacobs AK
    JACC Cardiovasc Interv; 2009 Jul; 2(7):611-3. PubMed ID: 19628182
    [No Abstract]   [Full Text] [Related]  

  • 4. Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
    Lansky AJ; Ng VG; Mutlu H; Cristea E; Guiran JB; Midei M; Newman W; Sanz M; Sood P; Doostzadeh J; Su X; White R; Cao S; Sudhir K; Stone GW
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):719-27. PubMed ID: 19530147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational studies of drug-eluting stents--some are more equal than others.
    Austin D; Oldroyd KG; Pell JP
    EuroIntervention; 2009 Jan; 4(4):419, 421, 423. PubMed ID: 19284062
    [No Abstract]   [Full Text] [Related]  

  • 6. DES editorial. Is there a survival benefit?
    Thomas DM
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):644-5. PubMed ID: 18360857
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Let it be, let it be.
    Butman SM
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):898. PubMed ID: 19455656
    [No Abstract]   [Full Text] [Related]  

  • 9. Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study.
    Garg S; Sarno G; Gutiérrez-Chico JL; Garcia-Garcia HM; Gomez-Lara J; Serruys PW;
    EuroIntervention; 2011 Apr; 6(9):1060-7. PubMed ID: 21518677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et al.
    Marx N
    Diab Vasc Dis Res; 2011 Apr; 8(2):173. PubMed ID: 21562069
    [No Abstract]   [Full Text] [Related]  

  • 11. The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129).
    Daemen J; van Twisk PH; Kukreja N; van Domburg RT; Boersma E; de Jaegere P; Serruys PW
    EuroIntervention; 2009 Jan; 4(4):464-74. PubMed ID: 19284068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetita iuvant.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):468-9. PubMed ID: 18819144
    [No Abstract]   [Full Text] [Related]  

  • 13. My stent is better than your stent...Or is it?
    Bates ER; Menees DS
    JACC Cardiovasc Interv; 2011 May; 4(5):551-3. PubMed ID: 21596328
    [No Abstract]   [Full Text] [Related]  

  • 14. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex difference in long-term clinical outcome after sirolimus-eluting stent implantation.
    Trabattoni D; Fabbiocchi F; Galli S; Montorsi P; Lualdi A; Grancini L; Ravagnani P; Bartorelli AL
    Coron Artery Dis; 2011; 22(6):442-6. PubMed ID: 21597366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
    Chacko R; Mulhearn M; Novack V; Novack L; Mauri L; Cohen SA; Moses J; Leon MB; Cutlip DE
    JACC Cardiovasc Interv; 2009 Jun; 2(6):498-503. PubMed ID: 19539252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and long-term outcomes of ostial stentings among bare-metal stents, sirolimus-eluting stents, and paclitaxel-eluting stents.
    Hsieh IC; Hsieh MJ; Chang SH; Wang CY; Lee CH; Lin FC; Chen CC
    Coron Artery Dis; 2013 May; 24(3):224-30. PubMed ID: 23571311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study.
    Rodriguez AE; Maree A; Tarragona S; Fernandez-Pereira C; Santaera O; Rodriguez Granillo AM; Rodriguez-Granillo GA; Russo-Felssen M; Kukreja N; Antoniucci D; Palacios IF; Serruys PW;
    EuroIntervention; 2009 Jun; 5(2):255-64. PubMed ID: 20449934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 20. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.